Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Market Cap $1.214B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BGP | Ann: BGP - Disclosure Notices Filed with NZX | 30/07/25 | 0 | 70 | |||
|
|||||||
BGP | Ann: Capital Change Notice filed with NZX | 30/07/25 | 0 | 82 | |||
|
|||||||
BGP | Ann: Results of Meeting | 15/05/25 | 0 | 166 | |||
|
|||||||
BGP | Ann: BGP Addresses to Annual Shareholders Meeting | 15/05/25 | 0 | 175 | |||
|
|||||||
BGP | Briscoe Group Sales Update: $178.3 Million | 07/05/25 | 0 | 105 | |||
|
|||||||
BGP | Ann: BGP 1st Quarter Sales to 27 April 2025 | 07/05/25 | 0 | 306 | |||
|
|||||||
BGP | Ann: Notice of General Meeting/Proxy Form | 09/04/25 | 0 | 207 | |||
|
|||||||
BGP | Ann: BGP Annual Report to Shareholders | 09/04/25 | 0 | 231 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |